Acid Red 87 structure
|
Common Name | Acid Red 87 | ||
|---|---|---|---|---|
| CAS Number | 17372-87-1 | Molecular Weight | 691.854 | |
| Density | 1.02 g/mL at 20 °C | Boiling Point | 682.3ºC at 760mmHg | |
| Molecular Formula | C20H6Br4Na2O5 | Melting Point | >300°C | |
| MSDS | Chinese USA | Flash Point | 11 °C | |
| Symbol |
GHS07 |
Signal Word | Warning | |
Use of Acid Red 87Eosin Y (disodium) is a soluble acid red dye molecule. Eosin Y has a wide application in organic synthesis as a photoredox catalyst[1]. |
| Name | eosin YS dye |
|---|---|
| Synonym | More Synonyms |
| Description | Eosin Y (disodium) is a soluble acid red dye molecule. Eosin Y has a wide application in organic synthesis as a photoredox catalyst[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.02 g/mL at 20 °C |
|---|---|
| Boiling Point | 682.3ºC at 760mmHg |
| Melting Point | >300°C |
| Molecular Formula | C20H6Br4Na2O5 |
| Molecular Weight | 691.854 |
| Flash Point | 11 °C |
| Exact Mass | 687.674377 |
| PSA | 81.65000 |
| LogP | 7.59220 |
| Water Solubility | freely soluble |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
MUTATION DATA
|
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H319 |
| Precautionary Statements | P305 + P351 + P338 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
| Hazard Codes | F,T,Xn,Xi |
| Risk Phrases | R11 |
| Safety Phrases | S7-S16-S36/37-S45-S24/25-S61-S39-S26 |
| RIDADR | UN 1230 3/PG 2 |
| WGK Germany | 1 |
| RTECS | LM5850000 |
| Hazard Class | 3.0 |
| HS Code | 3822001000 |
| HS Code | 2932999099 |
|---|---|
| Summary | 2932999099. other heterocyclic compounds with oxygen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
PI3K regulation of RAC1 is required for KRAS-induced pancreatic tumorigenesis in mice.
Gastroenterology 147(6) , 1405-16.e7, (2014) New drug targets are urgently needed for the treatment of patients with pancreatic ductal adenocarcinoma (PDA). Nearly all PDAs contain oncogenic mutations in the KRAS gene. Pharmacological inhibition... |
|
|
Chondrogenesis of human bone marrow mesenchymal stromal cells in highly porous alginate-foams supplemented with chondroitin sulfate.
Mater. Sci. Eng. C. Mater. Biol. Appl. 50 , 160-72, (2015) To overcome the limited intrinsic cartilage repair, autologous chondrocyte or bone-marrow-derived mesenchymal stromal cell (BM-MSC) was implanted into cartilage defects. For this purpose suitable bioc... |
|
|
Enhanced antitumor effects of the BRBP1 compound peptide BRBP1-TAT-KLA on human brain metastatic breast cancer.
Sci. Rep. 5 , 8029, (2015) Novel molecularly targeted agents that block the development and metastasis of human brain metastatic breast cancer hold great promise for their translational value. In this study, we constructed a no... |
| Acid Red 87 |
| Benzoic acid, 2-(2,4,5,7-tetrabromo-6-hydroxy-3-oxo-3H-xanthen-9-yl)-, sodium salt (1:2) |
| dawnred |
| bromo4d |
| Eosin Y,high purity,biological stain |
| eosin yellowish |
| 2',4',5',7'-tetrabromofluorescein) disodium salt |
| RED 22 |
| eosina |
| Eosin Y,Indicator grade |
| Bronze Bromo ES |
| Eosin Y water |
| Red A |
| 2',4',5',7'-Tetrabromofluorescein disodium salt |
| D & C Red no. 21 |
| eosine acid |
| 2na |
| tetrabromofluorescein |
| C.I. Solvent Red 43 |
| Bromo acid J. TS,XL,or XX |
| Tetrabromofluorescein Sodium Salt |
| Bromoeosine |
| EINECS 241-409-6 |
| bromofluoresceic acid |
| Eosin Y,certified |
| bromob |
| Bromofluorescein |
| Disodium 2-(2,4,5,7-tetrabromo-6-oxido-3-oxo-3H-xanthen-9-yl)benzoate |
| bromots |
| bromoxx |
| Red No. 22,Eosin yellowish |
| MFCD00131580 |
| bromofl |
| D&C Red No. 22 |
| Eosine Yellowish-(YS) |